ARCHIVES

Assembly of Scientists, started as a result of conflict of interest controversy, plans Sept. 14 meeting.

This article is from The Cancer Letter archive.

Vol. 31 No. 32 | September 9, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Durant To Retire From ASCO In A Year; Led Society Through Management Change

July 24, 1998

Letters: Subcommittee Report Full Of Errors, Gallo Attorney Says

February 3, 1995

Black Teens At Higher Risk Of Tobacco Addiction.

February 2, 2001

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004

In Brief: Susumu Tonegawa To Receive Bristol-Myers Award; Mark Green Named Director Of UCSD Cancer Center

March 7, 1986

Avon, NABCO Accepting Grant Applications For Community-Based Breast Cancer Programs

June 9, 1995